Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;28(3):303-13.
doi: 10.1055/s-0031-1284457.

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging

Affiliations

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging

Saher S Sabri et al. Semin Intervent Radiol. 2011 Sep.

Abstract

Balloon-occluded retrograde transvenous obliteration (BRTO) is an endovascular technique used as a therapeutic adjunct or alternative to transjugular intrahepatic shunts (TIPS) in the management of gastric varices. Occlusion balloons are strategically placed to modulate flow within the gastrorenal or gastrocaval shunt to allow stagnation of the sclerosant material within the gastric varix. The approach and complexity of the procedure depends on the anatomic classification of inflow and outflow veins of the varix. Ethanolamine oleate has been described as the main sclerosant used in this procedure. Recently, foam sclerosants have gained popularity as alternative embolization agents, which provide the advantage of better variceal wall contact and potentially less dose of sclerosant.

Keywords: BRTO; Gastric varices; embolization; liver cirrhosis; portal hypertension; portosystemic shunt.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Balloon-occluded retrograde transvenous obliteration procedural steps. (A) Catheterization of the gastrorenal shunt (arrow). (B) Advancement of an occlusion balloon (arrow) into the shunt and performing retrograde venogram. (C) Retrograde venogram shows opacification of the gastric varices (arrow) as well as the afferent posterior gastric vein (arrow heads). (D) Administration of the sclerosant mixture with the endpoint being filling of the afferent posterior gastric vein (arrowheads).
Figure 2
Figure 2
Classification based on venous drainage. (A) Type A has a shunt with a single draining vein. (B) Type B has a shunt with multiple collateral draining veins. (C) Type C has both a gastrocaval and gastrorenal shunt. (D) Type D has multiple small draining veins and no shunt.
Figure 3
Figure 3
Type A venous outflow. (A) With the occlusion balloon (arrowheads) positioned at the base of the gastrorenal shunt, balloon-occluded retrograde venography shows filling of the gastric varices as well as the afferent vein (arrow). (B) With the occlusion balloon (arrowheads) inflated, the sclerosant was administered with minimal filling of the afferent vein (arrow). (C) Overview of type A venous outflow treatment.
Figure 4
Figure 4
Type B venous outflow. (A) With the occlusion balloon (arrowheads) positioned at the base of the gastrorenal shunt, balloon-occluded retrograde venography shows filling of multiple “leaking” collateral veins including inferior phrenic (black arrow) and perivertebral veins (white arrow).(B) After the occlusion balloon (arrowheads) was advanced beyond the “leaking” collateral veins, venography through a microcatheter (white arrow) now shows opacification of the gastric varices (black arrow).
Figure 5
Figure 5
Type B venous outflow. (A) With the occlusion balloon (arrowheads) positioned at the base of the gastrorenal shunt, balloon-occluded retrograde venography shows filling of the inferior phrenic vein (black arrow). (B) Using a microcatheter (arrow), the vein was catheterized and embolized using metallic coils. (C) With the occlusion balloon (arrowheads) inflated, the sclerosant was administered with minimal filling of the afferent vein (arrow). (D) Overview of type B venous outflow using metallic coils.
Figure 6
Figure 6
Type C venous outflow. (A) With the occlusion balloon positioned at the base of the gastrorenal shunt (not shown), balloon-occluded retrograde venography through a microcatheter (black arrow) shows filling of a gastrocaval shunt (white arrows). (B) A second occlusion balloon was advanced to occlude the gastrocaval shunt (arrowheads) .The sclerosant was administered through a microcatheter (white arrow) with opacification of the varices and minimal filling of the afferent vein (black arrow). (C) Overview of type C venous outflow treatment with a second occlusion balloon.
Figure 7
Figure 7
Classification based on venous inflow. (A) Type 1 gastric varices are supplied by a single afferent gastric vein. This is the most common and simplest type to treat. (B) In type 2, the gastric varices are supplied by multiple afferent gastric veins; and (C) type 3, by single or multiple gastric veins with coexistent gastric veins that are directly contiguous with the shunt, but do not contribute to the varices.
Figure 8
Figure 8
Cone beam computed tomography (CT) utilization in a balloon-occluded retrograde transvenous obliteration procedure. (A) Contrast-enhanced CT scan shows gastric fundal varices (arrow). (B) Cone beam CT after administration of the sclerosant showed opacification of the same gastric fundal varices (arrow).

References

    1. Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16(6):1343–1349. - PubMed
    1. Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25(2):307–312. - PubMed
    1. Ryan B M, Stockbrugger R W, Ryan J M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126(4):1175–1189. - PubMed
    1. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330(3):165–171. - PubMed
    1. Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol. 2001;96(12):3379–3383. - PubMed